Should We Send TURP Histology for Pathological Examination?
European Urology Focus · 2026-09 · 12 (4) · 668-671
DOI: 10.1016/j.euf.2026.07.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Urology Focus, 2026-09. Verfasst von Heikki Seikkula und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Turku and Turku University Hospital, Turku, Finland. Electronic address: heikki.seikkula@varha.fi. Hauptthemen laut MEDLINE: Transurethral Resection of Prostate, Prostatic Neoplasms, Prostatic Hyperplasia, Prostate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Transurethral resection of the prostate (TURP) has historically provided tissue for histological assessment as a by-product of surgery, but contemporary prostate cancer (PCa) pathways increasingly rely on risk stratification before surgery for benign prostatic obstruction. Although modern series suggest that incidental PCa detected in TURP specimens is relatively common, it is predominantly low grade and managed conservatively. Moreover, transition zone cancers, which are typically sampled by TURP, may show more favorable pathological features and recurrence outcomes than peripheral zone cancers, suggesting a lower risk of missing aggressive disease if routine TURP chip analysis is omitted. Routine processing is also resource intensive, may cause psychological harm, and is costly. These findings do not support routine histological examination of TURP chips in men with low preoperative suspicion of patient-important PCa and instead support evaluation of a risk-adapted strategy. PATIENT SUMMARY: Transurethral resection of the prostate is an operation to remove prostate tissue blocking urine flow. Sometimes cancer is found unexpectedly in this tissue. Most such cancers are small, slow growing, and unlikely to cause harm. Avoiding routine tissue testing may reduce worry and unnecessary follow-up while still allowing patients at higher risk to undergo selective histological evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of Turku and Turku University Hospital, Turku, Finland. Electronic address: heikki.seikkula@varha.fi.
- Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Pathology, Fimlab Laboratories Ltd, Tampere, Finland.
- Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Public Health, University of Helsinki, Helsinki, Finland; Department of Health Research Methods, Evidence…
- Department of Urology, Tampere University and Tampere University Hospital, Tampere, Finland.
Zitieren
APA
Seikkula, H., Santti, H., Laurila, M., Tikkinen, K. A. O., & Pekkarinen, T. (2026). Should We Send TURP Histology for Pathological Examination?. European Urology Focus, 12(4), 668-671. https://doi.org/10.1016/j.euf.2026.07.020
Vancouver
Seikkula H, Santti H, Laurila M, Tikkinen KAO, Pekkarinen T. Should We Send TURP Histology for Pathological Examination?. European Urology Focus. 2026;12(4):668-671. doi:10.1016/j.euf.2026.07.020
BibTeX
@article{Seikkula2026,
author = {Seikkula, Heikki and Santti, Henrikki and Laurila, Marita and Tikkinen, Kari A O and Pekkarinen, Tarmo},
title = {Should We Send TURP Histology for Pathological Examination?},
journal = {European Urology Focus},
year = {2026},
volume = {12},
number = {4},
pages = {668--671},
doi = {10.1016/j.euf.2026.07.020}
}
EUVIMED